...
首页> 外文期刊>Fetal diagnosis and therapy >Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers
【24h】

Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers

机译:根据妊娠期母体因子和血清标记的血清妇女预测预测

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Objective: To evaluate the performance of maternal risk factors (BMI and mean arterial pressure [MAP]) and first-trimester maternal serum markers in the early prediction of preeclampsia (PE) in nulliparous women. Material and Methods: This was a case-cohort study based on a cohort of 14,207 nulliparous women. A total of 213 cases with term PE (from 37 weeks + 0 days) and 55 cases with preterm PE (before 37 weeks + 0 days) were identified and validated. Randomly, 449 controls were selected. Serum samples previously collected for the double test (pregnancy-associated plasma protein A [PAPP-A] and free β human chorionic gonadotrophin [hCGβ]) as part of the first-trimester screening program were retrieved and analyzed for placental growth factor (PlGF), soluble fms-like tyrosine kinase 1 (sFlt-1), N-terminal pro-B-type natriuretic peptide (NT-proBNP), and neutrophil gelatinase-associated lipocalin (NGAL). Concentrations were transformed to multiples of the median (MoM). Multivariate regression analysis was used for prediction models. Receiver-operating characteristics (ROC) curves were used for evaluation of the screening performance. Results: In preterm PE, the PlGF (0.79 MoM), sFlt-1 (0.86 MoM), NGAL (1.15 MoM), and PAPP-A (0.89 MoM) medians were significantly altered. In term PE, PlGF (0.90 MoM) and NT-proBNP (0.86 MoM) medians were significantly reduced. The combination of MAP and PlGF yielded a 39% detection rate of preterm PE for a 10% false-positive rate. The combination of MAP, BMI, and PlGF yielded a 33% detection rate of term PE with a 10% false-positive rate. Conclusion: First-trimester MAP, maternal serum PlGF, and NGAL are markers of preterm PE. Maternal serum sFlt-1 is a significant marker of preterm PE, but only early in the first trimester. First-trimester maternal serum NT-proBNP is not a predictor of PE. Screening performance for PE with these markers individually or in combination is modest.
机译:目的:评价母体风险因素(BMI和平均动脉压[地图])和初期母体血清标志物的性能,在零液化女性早期预测中预测预测。材料和方法:这是一个基于14,207个无污染妇女的队列的案件队列研究。鉴定并验证,共有213例术语PE(从37周+ 0天)和55例(37周之前)(37周+ 0天之前)。随机,选择了449个控件。检测和分析作为胎盘生长因子(PLGF)的一部分作为第一三节筛选程序的一部分作为第一三节筛选程序的一部分作为第一三节筛选程序的血清试验(妊娠相关血浆蛋白A [PAPP-A]和游离β人绒毛膜促性腺激素[HCGβ])的血清样品。 ,可溶性FMS样酪氨酸激酶1(SFLT-1),N-末端Pro-B型利钠肽(NT-PROPNP)和中性粒细胞明胶酶相关的脂素(NGAL)。将浓度转化为中位数(MOM)的倍数。多变量回归分析用于预测模型。接收器操作特性(ROC)曲线用于评估筛选性能。结果:在早产PE,PLGF(0.79 mom),SFLT-1(0.86妈妈),NGAL(1.15妈妈)和PAPP-A(0.89妈妈)中位数被显着改变。在术语PE中,PLGF(0.90母亲)和NT-PROPNP(0.86妈妈)中位数显着降低。 MAP和PLGF的组合产生了10%假阳性率的预筛度的39%的检测率。地图,BMI和PLGF的组合产生了术语PE的33%,具有10%的假阳性率。结论:孕孕孕妇地图,母体血清PLGF和NGAL是早产PE的标志物。母体血清SFLT-1是早产PE的重要标志物,但仅在前三个月的早期。孕孕前孕妇血清NT-probnp不是PE的预测因子。单独或组合使用这些标记的PE筛选性能是适度的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号